A bipartisan group of legislators in the House of Representatives reintroduced a bill to allow Medicare to cover state authorized pharmacist services. The bill, known as the Pharmacy in Medically Underserved Areas Enhancement Act, makes the same changes to the Social Security Act proposed by HR 4190, first introduced last year. The text of the new bill, known as HR 592, is publicly available online. [click to continue…]
The National Governors Association (NGA) recently released a report to encourage states that are looking to increase their primary care capacity to change legislation to allow pharmacists from doing work they are qualified to do. The report identifies several barriers including “restrictive laws and regulations governing collaborative practice agreements,” a “lack of provider recognition in federal and state law governing compensation of pharmacist to provide direct patient care services,” and “limitations on pharmacists ability to access health information systems.” [click to continue…]
At the end of January, the FDA announced approval for Bexsero, a Novartis vaccine designed to protect against invasive meningococcal disease caused by the serogroup B bacteria, Neisseria meningitidis. [click to continue…]
Colorectal cancer is the fourth most common cancer in America, and the second leading cause of death from cancer. It affects people across all racial and ethnic groups, but is most commonly found in people over age 50.
If all patients over age 50 were screened on a regular basis, 60% of deaths from colorectal cancer could be prevented. Use this month to raise awareness about colorectal cancer screenings and prevention in your community. [click to continue…]
In late December 2014, Valeant Pharmaceuticals voluntarily recalled a single lot of ribavirin powder, sold under the brand name Virazole, because there were concerns with the stability of the product. The FDA is aware of the recall and is working with the company to facilitate it.
The company says that 12-month testing of Lot 340353F showed a positive sterility test result, but the company did not identify what contaminated the powder. The medication was distributed throughout the United States and Australia. All other lots are unaffected and thus not involved in the recall. [click to continue…]
In mid-December, Baxter International recalled two lots of Sodium Chloride Injection. This particular recall affected 100-ML mini bags and containers of 0.9% sodium chloride. The recall was made voluntarily after the company received reports of particulate matter in the product. [click to continue…]